Category: Press Release - Page 24 - Psychedelic Alpha

Read more about the article FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF PHASE II CLINICAL TRIAL STUDYING PSILOCYBIN FOR METHAMPHETAMINE USE DISORDER

FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF PHASE II CLINICAL TRIAL STUDYING PSILOCYBIN FOR METHAMPHETAMINE USE DISORDER

Post published:March 15, 2023
Post category:Press Release

Read more about the article CORRECTION — BetterLife Closes $1,857,143 of Private Placement

CORRECTION — BetterLife Closes $1,857,143 of Private Placement

Post published:March 14, 2023
Post category:Press Release

Read more about the article Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Post published:March 14, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

Post published:March 14, 2023
Post category:Press Release

Read more about the article BetterLife Closes $1,857,143 of Private Placement

BetterLife Closes $1,857,143 of Private Placement

Post published:March 14, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Files Lawsuit Against Mindset Pharma

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

Post published:March 13, 2023
Post category:Press Release

Read more about the article BetterLife Files Amended and Restated Offering Document for Offering of Units

BetterLife Files Amended and Restated Offering Document for Offering of Units

Post published:March 11, 2023
Post category:Press Release

Read more about the article Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”

Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”

Post published:March 9, 2023
Post category:Press Release

Read more about the article BetterLife Announces Pricing of Proposed Offering of Units

BetterLife Announces Pricing of Proposed Offering of Units

Post published:March 8, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Provides Update From Type C Meeting with FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Post published:March 8, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.